BioCanRx’s vision is to cure patients and enhance the quality of life of those living with cancer.
BioCanRx does this by supporting world-class research in the area of immune oncology, and by accelerating to the clinic the most promising cancer immunotherapies designed to save lives and enable a better quality of life.
Through an innovative, collaborative funding process BioCanRx is becoming a world-leader in the translation, manufacture and adoption of leading edge cancer immunotherapy treatments for the benefit of cancer patients.
Awards
2016
Recipient
Award type
Research Trainee award
Project title
Toward personalized immunotherapy: defining mechanisms of immune suppression across the molecular subtypes of ovarian cancer
Recipient
Kyla CochraneAward type
Research Trainee award
Project title
Determining the virulence determinants of Fusobacterium nucleatum to define diagnostic and therapeutic targets for colorectal cancer